Emilia T Mcgloin, LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 927 Rest Church Rd, Clear Brook, VA 22624 Phone: 540-327-9218 |
News Archive
AVANIR Pharmaceuticals, Inc. today announced efficacy, safety and tolerability results from the 12-week open-label extension phase of the confirmatory Phase III STAR trial evaluating the investigational drug Zenvia™ (dextromethorphan/quinidine) in the treatment of patients with pseudobulbar affect (PBA).
A new service is being launched today: wound care teleassistance, also known as téléassistance en soins de plaies (TASP). With this service a nurse can use a camera to film her patient's wound, while at the same time an expert nurse in another institution can receive the images. They can then hold an online discussion to evaluate the patient's wound and plan treatment.
Scientists at Rice University are enhancing the natural antioxidant properties of an element found in a car's catalytic converter to make it useful for medical applications.
Support for the development and application of this electronic nose comes from the National Institute of Environmental Health Sciences, part of the National Institutes of Health. The new technology is discussed in this month's issue of Nature Chemistry and exemplifies the types of sensors that are being developed as part of the NIH Genes, Environment and Health Initiative (GEI).
› Verified 5 days ago